SCHEMBL21753656

SCHEMBL21753656

Cc1cc(ONC(=O)Cc2ccccc2C)n(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NTRK1 P04629 2/20 0.45
HTT P42858 2/20 0.44
P2RX7 Q99572 3/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPK1 P28482 1/20 0.43
GAA P10253 1/20 0.43
CACNA1G O43497 1/20 0.42
CACNA1H O95180 1/20 0.42
CACNA1I Q9P0X4 1/20 0.42
P2RY1 P47900 1/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
KCNJ6 P48051 1/20 0.42
KCNJ5 P48544 1/20 0.42
KCNJ3 P48549 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21753616 0.84 ALDH1A1 (0.50) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL21753627 0.82 ALDH1A1 (0.48) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL21753652 0.80 KMT2A (0.51) ALDH1A1NTRK1MAPTKMT2AMAPK1
SCHEMBL21753629 0.79 P2RY1 (0.51) ALDH1A1ATML3MBTL1NTRK1MAPT
SCHEMBL28883960 0.78 ALDH1A1 (0.45) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL21753619 0.77 NTRK1 (0.50) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL28884502 0.76 ALDH1A1 (0.43) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL21753632 0.76 ALDH1A1 (0.43) ALDH1A1ATML3MBTL1NTRK1HTT
SCHEMBL25285703 0.76 P2RY1 (0.44) ALDH1A1ATML3MBTL1NTRK1MAPT
SCHEMBL28361113 0.76 ALDH1A1 (0.43) ALDH1A1ATML3MBTL1NTRK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
US-20220372058-A1 Substituted Pyrazole Compound, Preparation Method Therefor, Pharmaceutical Composition and Medical Use Thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD (CN) 2022-11-24 US disclosed
WO-2020038279-A1 SUBSTITUTED PYRAZOLE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 天津谷堆生物医药科技有限公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220372058-A1 Substituted Pyrazole Compound, Preparation Method Therefor, Pharmaceutical Composition and Medical Use Thereof FARS2, GOT2, HADHB ALDH1A1 2197/4885ATM 2497/4885L3MBTL1 1066/4885
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof FARS2, GOT2, HADHB ALDH1A1 2197/4885ATM 2497/4885L3MBTL1 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.